Skip to main content

Table 1 Descriptive characteristics of patients by multimorbidity or non-multimorbidity group (1,749,710 adult patients, Catalonia, 2010)

From: The burden of cardiovascular morbidity in a European Mediterranean population with multimorbidity: a cross-sectional study

 

Multimorbidity group

Non-multimorbidity group

Total

 

Cardiovascular morbidity

Non-cardiovascular morbidity

  

Variables

(n = 442,816)

(n = 375,355)

(n = 931,539)

(N = 1,749,710)

Age (years)

65.7 (14.6)

48.2 (15.4)

38.3 (12.7)

47.4 (17.8)

Sex (% females)

56.1

57.5

45.5

50.7

Number of chronic diseases (median, IQR)

5.0 (3.0;7.0)

3.0 (2.0;4.0)

0.0 (0.0;1.0)

1.0 (0.0;3.0)

Visits (median, IQR)

10.0 (6.0;18.0)

6.0 (3.0;11.0)

1.0 (0.0;4.0)

4.0 (1.0;9.0)

Urban setting (%)

83.4

84.0

84.2

84.0

Physical examination

 BMI (kg/cm2) (n= 509,368)

29.7 (5.1)

28.0 (5.4)

26.0 (4.7)

28.3 (5.3)

 Systolic BP (mm Hg) (n = 773,446)

135.2 (16.2)

126.6 (14.6)

123.8 (14.9)

129.7 (16.3)

 Diastolic BP (mm Hg) (n = 774,139)

76.7 (10.3)

76.0 (9.6)

74.5 (10.1)

75.9 (10.1)

Laboratory tests

 Glycated haemoglobin (%)(SD) (n = 208,581)

6.6 (1.3)

6.3 (1.5)

5.7 (1.2)

6.4 (1.4)

 Creatinine (mg/dl) (SD) (n = 738,083)

0.9 (0.4)

0.8 (0.2)

0.8 (0.2)

0.9 (0.3)

 Uric acid (mg/dl) (SD) (n = 475, 334)

5.5 (1.6)

4.8 (1.4)

4.8 (1.4)

5.2 (1.5)

 Total cholesterol (mg/dl) (SD) (n = 745,010)

202.0 (39.7)

209.0 (40.6)

194.3 (38.4)

201.8 (40.0)

 Triglycerides (mg/dl) (SD) (n = 190,159)

132.9 (82.9)

129 (98.7)

113.3 (75.7)

127.5 (86.4)

 Glomerular filtration rate < 60 % (%) (n = 544,438)

17.6

3.2

1.3

9.2

  1. p-values overall between multimorbidity and non-multimorbidity groups were significant for all variables (p < 0.001)